160 Health International Limited (HKG:2656)

160 Health International Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	651.87	620.68	628.61	525.65
Revenue Growth (YoY)	5.02%	-1.26%	19.59%	-
Cost of Revenue	481.71	460.5	491.28	407.36
Gross Profit	170.16	160.19	137.33	118.29
Selling, General & Admin	201.12	210.26	191.48	137.25
Research & Development	34.96	50.51	41.7	54.06
Other Operating Expenses	8.52	-3.83	-4.41	-7.24
Operating Expenses	244.6	265.12	236.1	184.83
Operating Income	-74.44	-104.94	-98.77	-66.55
Interest Expense	-6.24	-3.66	-11.37	-40.14
Interest & Investment Income	-	1.33	0.21	0.37
Currency Exchange Gain (Loss)	-	0.42	-0.33	-
Other Non Operating Income (Expenses)	3.35	-0.1	-0.01	-0.25
EBT Excluding Unusual Items	-77.33	-106.95	-110.27	-106.57
Gain (Loss) on Sale of Assets	-	-0.01	-0.03	-0
Legal Settlements	-	-	-0.39	-12.4
Other Unusual Items	-	-0	-	0.02
Pretax Income	-77.33	-106.96	-110.68	-118.96
Income Tax Expense	-2.8	1.29	0.55	-
Earnings From Continuing Operations	-74.53	-108.25	-111.22	-118.96
Earnings From Discontinued Operations	-	-	5.02	-0.57
Net Income to Company	-74.53	-108.25	-106.2	-119.52
Minority Interest in Earnings	1.55	0.56	-2.62	8.22
Net Income	-72.99	-107.69	-108.82	-111.31
Net Income to Common	-72.99	-107.69	-108.82	-111.31
Shares Outstanding (Basic)	304	294	291	286
Shares Outstanding (Diluted)	304	294	291	286
Shares Change (YoY)	3.46%	1.18%	1.71%	-
EPS (Basic)	-0.24	-0.37	-0.37	-0.39
EPS (Diluted)	-0.24	-0.37	-0.37	-0.39
Free Cash Flow	-114.44	-56.99	-67.23	-44.88
Free Cash Flow Per Share	-0.38	-0.19	-0.23	-0.16
Gross Margin	26.10%	25.81%	21.85%	22.50%
Operating Margin	-11.42%	-16.91%	-15.71%	-12.66%
Profit Margin	-11.20%	-17.35%	-17.31%	-21.18%
Free Cash Flow Margin	-17.55%	-9.18%	-10.70%	-8.54%
EBITDA	-71.07	-101.56	-94.96	-63.23
EBITDA Margin	-10.90%	-16.36%	-15.11%	-12.03%
D&A For EBITDA	3.37	3.37	3.81	3.31
EBIT	-74.44	-104.94	-98.77	-66.55
EBIT Margin	-11.42%	-16.91%	-15.71%	-12.66%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.